Ketanserin is a quinazoline derivative and serotonin (5-hydroxytryptamine, 5HT) receptor subtype 2 (5-HTR2) antagonist with potential antihypertensive and antiplatelet activities. Following administration, ketanserin binds to and inhibits the signaling mediated by 5-HTR2, which inhibits serotonin-dependent vasoconstriction and platelet activation. Its therapeutic use is listed as cardiovascular. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Ketanserinum and Ketanserina. Its PubChem CID is 3822.
Ketanserin
| CAS No | 83846-83-7 |
|---|---|
| Molecular Formula | C22H22FN3O3 |
| Molecular Weight | 395.4 g/mol |
| Synonyms | 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ketanserin is a quinazoline derivative and serotonin (5-hydroxytryptamine, 5HT) receptor subtype 2 (5-HTR2) antagonist with potential antihypertensive and antiplatelet activities.
The listed CAS number is 83846-83-7.
The listed molecular formula is C22H22FN3O3.
The listed molecular weight is 395.4 g/mol.
3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione.
The source lists Ketanserinum and Ketanserina.